Private equity firm Ardian is acquiring a minority stake in IVB Wellness Lab, a specialized supplementation laboratory. IVB focuses on science-based products targeting metabolic health and hormonal balance. This deal provides the company with capital to expand its research and manufacturing capabilities while allowing Ardian to enter the growing wellness sector without taking full control of the business.

The supplement market has seen a surge in demand for clinically-backed products, moving away from generic vitamins. IVB's lab-based approach appeals to consumers seeking transparency and efficacy. For Ardian, a minority investment offers a strategic foothold in this niche, leveraging IVB's scientific reputation to capture market share in the premium wellness category.

Both companies are keeping deal terms private. The partnership will likely focus on scaling IVB's distribution channels and accelerating new product development. Watch for IVB to push deeper into personalized nutrition, a trend reshaping how consumers approach daily health maintenance and preventative care.